HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hispolon from Phellinus linteus has antiproliferative effects via MDM2-recruited ERK1/2 activity in breast and bladder cancer cells.

Abstract
The MDM2 proto-oncogene is overexpressed in many human tumors. Although MDM2 inhibits tumor-suppressor function of p53, there exists a p53-independent role for MDM2 in tumorigenesis. Therefore, downregulation of MDM2 has been considered an attractive therapeutic strategy. Hispolon extracted from Phellinus species was found to induce epidermoid and gastric cancer cell apoptosis. However, the mechanisms are not fully understood. Herein, we report our findings that hispolon inhibited breast and bladder cancer cell growth, regardless of p53 status. Furthermore, p21(WAF1), a cyclin-dependent kinase inhibitor, was elevated in hispolon-treated cells. MDM2, a negative regulator of p21(WAF1), was ubiquitinated and degraded after hispolon treatment. We also found that activated ERK1/2 (extracellular signal-regulated kinase1/2) was recruited to MDM2 and involved in mediating MDM2 ubiquitination. Based on this finding, we investigated whether the sensitivity of cells to hispolon was related to ERK1/2 activity. The results indicated that cells with higher ERK1/2 activity were more sensitive to hispolon. In addition, hispolon-induced caspase-7 cleavage was inhibited by the ERK1/2 inhibitor, U0126. In conclusion, hispolon ubiquitinates and downregulates MDM2 via MDM2-recruited activated ERK1/2. Therefore, hispolon may be a potential anti-tumor agent in breast and bladder cancers.
AuthorsTe-Ling Lu, Guan-Jhong Huang, Te-Jung Lu, Jin-Bin Wu, Chieh-Hsi Wu, Tung-Chuan Yang, Akira Iizuka, Yuh-Fung Chen
JournalFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association (Food Chem Toxicol) Vol. 47 Issue 8 Pg. 2013-21 (Aug 2009) ISSN: 1873-6351 [Electronic] England
PMID19477214 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibiotics, Antineoplastic
  • Catechols
  • Indicators and Reagents
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Tumor Suppressor Protein p53
  • hispolon
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2
  • Poly(ADP-ribose) Polymerases
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Caspase 7
Topics
  • Agaricales (chemistry)
  • Antibiotics, Antineoplastic (chemistry)
  • Apoptosis (drug effects)
  • Breast Neoplasms (drug therapy, enzymology, pathology)
  • Caspase 7 (biosynthesis)
  • Catechols (isolation & purification, pharmacology)
  • Cell Cycle (drug effects)
  • Cell Line, Tumor
  • Cell Nucleus (drug effects, ultrastructure)
  • Enzyme Induction
  • Female
  • Flow Cytometry
  • Humans
  • Immunoprecipitation
  • Indicators and Reagents
  • Mitogen-Activated Protein Kinase 1 (antagonists & inhibitors, chemistry)
  • Mitogen-Activated Protein Kinase 3 (antagonists & inhibitors, chemistry)
  • Poly(ADP-ribose) Polymerases (metabolism)
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins c-mdm2 (genetics, physiology)
  • Tumor Suppressor Protein p53 (metabolism)
  • Urinary Bladder Neoplasms (drug therapy, enzymology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: